Detalhe da pesquisa
1.
A multimodal atlas of hepatocellular carcinoma reveals convergent evolutionary paths and 'bad apple' effect on clinical trajectory.
J Hepatol
; 2024 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38782118
2.
Hypoxia-driven immunosuppression by Treg and type-2 conventional dendritic cells in HCC.
Hepatology
; 76(5): 1329-1344, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35184329
3.
Multi-region sampling with paired sample sequencing analyses reveals sub-groups of patients with novel patient-specific dysregulation in Hepatocellular Carcinoma.
BMC Cancer
; 23(1): 118, 2023 Feb 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36737737
4.
IFNγ-IL-17+ CD8 T cells contribute to immunosuppression and tumor progression in human hepatocellular carcinoma.
Cancer Lett
; 552: 215977, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36279983
5.
A genomic enhancer signature associates with hepatocellular carcinoma prognosis.
JHEP Rep
; 5(6): 100715, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37168287
6.
Genome instability is associated with ethnic differences between Asians and Europeans in hepatocellular carcinoma.
Theranostics
; 12(10): 4703-4717, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35832070
7.
Dynamic phenotypic heterogeneity and the evolution of multiple RNA subtypes in hepatocellular carcinoma: the PLANET study.
Natl Sci Rev
; 9(3): nwab192, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35382356
8.
Trajectory of immune evasion and cancer progression in hepatocellular carcinoma.
Nat Commun
; 13(1): 1441, 2022 03 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35301339
9.
Intratumoural immune heterogeneity as a hallmark of tumour evolution and progression in hepatocellular carcinoma.
Nat Commun
; 12(1): 227, 2021 01 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33431814
10.
Author Correction: Intratumoural immune heterogeneity as a hallmark of tumour evolution and progression in hepatocellular carcinoma.
Nat Commun
; 12(1): 1372, 2021 Feb 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-33623020